Table 1 Baseline characteristics of patients by study
Site | Year | Drug | Enrolled n | Males n (%) | Age | Weight mean kgs (range) | Parasitaemia (/ml) geometric mean (range) | |
|---|---|---|---|---|---|---|---|---|
Mean years (range) | >15 years n (%) | |||||||
Muse | 2011–12 | AL | 55 | 45 (81.8) | 22.8 (5–56) | 44 (80) | 56.9 (30–70) | 3745 (1002–76,421) |
Muse | 2011–12 | AS + MQ | 45 | 41 (91.1) | 29.6 (16–65) | 45 (100) | 59.4 (50–65) | 3210 (1000–54,436) |
Tamu | 2012 | AL | 74 | 64 (86.5) | 33.2 (11–60) | 71 (95.9) | 55.8 (30–70) | 3494 (1002–31,492) |
Tamu | 2012 | AS + MQ | 74 | 62 (83.8) | 36.6 (13–64) | 73 (98.6) | 58 (40–75) | 3774 (1081–15,310) |
Tabeikkyin | 2014 | AL | 75 | 52 (69.3) | 36.6 (8–60) | 74 (98.7) | 52.9 (30–65) | 4251 (1524–12,244) |
Tabeikkyin | 2014 | DP | 72 | 60 (83.3) | 35.6 (12–65) | 71 (98.6) | 55 (32–65) | 4408 (1063–16,424) |
Tamu | 2014 | DP | 75 | 50 (66.7) | 39 (10–74) | 72 (96.0) | 56.9 (32–75) | 5199 (2556–14,664) |